menu
    • menu

    Company profile for CHIESI USA INC

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cornerstone Therapeutics Inc. is now Chiesi USA, Inc. We are pleased to announce that a strong partnership which began in 2009 has resulted in the complete acquisition of Cornerstone Therapeutics Inc. by Chiesi Farmaceutici S.p.A. Along with a corporate name change to Chiesi USA, Inc. we are now a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. This transaction did not constitute a change of control for Cornerstone as C...
    Cornerstone Therapeutics Inc. is now Chiesi USA, Inc. We are pleased to announce that a strong partnership which began in 2009 has resulted in the complete acquisition of Cornerstone Therapeutics Inc. by Chiesi Farmaceutici S.p.A. Along with a corporate name change to Chiesi USA, Inc. we are now a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. This transaction did not constitute a change of control for Cornerstone as Chiesi has owned a majority of Cornerstone’s outstanding shares since 2009. Effective March 13, 2014, Cornerstone Therapeutics Inc. changed its name to “Chiesi USA, Inc.”

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CHIESI USA INCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    175 Regency Woods Place, Suite 600, Cary, NC 27518
    Telephone
    Telephone
    (888) 466-6505/6511
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.chiesiusa.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chiesi To Present Respiratory Leadership Data At ATS 2024
    Chiesi To Present Respiratory Leadership Data At ATS 2024

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883338/0/en/Chiesi-to-Present-New-Data-Showcasing-Depth-of-Respiratory-Leadership-at-the-American-Thoracic-Society-2024-International-Conference.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    Chiesi USA CEO Appointed to ASHP Foundation Board of Directors
    Chiesi USA CEO Appointed to ASHP Foundation Board of Directors

    20 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/20/2708249/0/en/Chiesi-USA-CEO-Appointed-to-ASHP-Foundation-Board-of-Directors.html

    GLOBENEWSWIRE
    20 Jul 2023
    Share Share
    Chiesi USA Partners with Smith Anderson to Host 1L Excellence
    Chiesi USA Partners with Smith Anderson to Host 1L Excellence

    12 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/12/2686335/0/en/Chiesi-USA-Partners-with-Smith-Anderson-to-Host-1L-Excellence-in-Diversity-Fellow-this-Summer.html

    GLOBENEWSWIRE
    12 Jun 2023
    Share Share
    Chiesi Farmaceutici's Elfabrio (Pegunigalsidase alfa) Receives Approval in the Europe
    Chiesi Farmaceutici's Elfabrio (Pegunigalsidase alfa) Receives Approval in the Europe

    25 May 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/elfabrio-epar-medicine-overview_en.pdf

    EMA
    25 May 2023
    Share Share
    2022 for Chiesi: The Group international growth continues
    2022 for Chiesi: The Group international growth continues

    11 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/11/2644473/0/en/2022-for-Chiesi-The-Group-s-international-growth-continues.html

    GLOBENEWSWIRE
    11 Apr 2023
    Share Share
    Chiesi's international growth continues
    Chiesi's international growth continues

    05 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chiesis-international-growth-continues-301790653.html

    PR NEWSWIRE
    05 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search